Skip to content

Emmaus Life Sciences, Inc.

EMMA· OTCCore metricsCIK 822370

Pharmaceutical preparations553 peers

Close
Aug 31, 2026 · -25.00%
Market cap
$4.21M
70.19M shares
Filings
1,003
$6.32M
Q2 2026−25.2% FY25 yoy
$1.34M
Q2 2026N/M FY25 yoy
$3.79M
Q2 2026N/M FY25 yoy
$1.35M
Q2 2026derivedN/M FY25 yoy
$0.02
Q2 2026N/M FY25 yoy
$2.81M
Q2 2026+53.1% FY25 yoy
$4.21M
—
0.3×
—
—
—

Twelve months to Jun 30, 2026 · derived

Price

$0.06+100.00%+$0.03since Aug 21, 2026
Aug 31, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$12.45MFY 2025
$29.60M0FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$12,453,000reported
FY 20242024-12-31$16,653,000reported
FY 20232023-12-31$29,597,000reported
FY 20222022-12-31$18,390,000reported
FY 20212021-12-31$20,610,000reported
FY 20202020-12-31$23,167,000reported
FY 20192019-12-31$22,752,000reported
FY 20182018-12-31$16,459,000reported
FY 20172017-09-30$128,500reported

Segments

Products
Revenue by Products, FY2018 to FY2025FY2018Other · FY2018 · $506.00KEndari · FY2018 · $15.95MFY2019Other · FY2019 · $441.00KEndari · FY2019 · $22.31MFY2020Other · FY2020 · $603.00KEndari · FY2020 · $22.56MFY2021Other · FY2021 · $493.00KEndari · FY2021 · $20.12MFY2022Other · FY2022 · $536.00KEndari · FY2022 · $17.85MFY2023Endari - US · FY2023 · $22.00MEndari - International · FY2023 · $6.96MOther · FY2023 · $636.00KEndari · FY2023 · $28.96MFY2024Endari - US · FY2024 · $13.48MEndari - International · FY2024 · $2.67MOther · FY2024 · $506.00KFY2025Endari - US · FY2025 · $9.05MEndari - International · FY2025 · $3.18MOther · FY2025 · $225.00K
LineFY2025ShareChange
Endari - US$9.05M73%−32.9%
Endari - International$3.18M26%+19.1%
Other$225.00K1.8%−55.5%
Endari———
Total$12.45M

From the 10-K filed Mar 31, 2026EMMA

Pharmaceutical preparations

Emmaus Life Sciences, Inc. is the 165th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Emmaus Life Sciences, Inc. · CIK 822370 · Engraved from SEC EDGAR